ANGLE plc

LSE AGL.L

ANGLE plc Market Capitalization on January 14, 2025: USD 46.26 M

ANGLE plc Market Capitalization is USD 46.26 M on January 14, 2025, a -46.24% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

ANGLE plc 52-week high Market Capitalization is USD 94.97 M on May 15, 2024, which is 105.28% above the current Market Capitalization.
ANGLE plc 52-week low Market Capitalization is USD 30.33 M on October 28, 2024, which is -34.44% below the current Market Capitalization.
ANGLE plc average Market Capitalization for the last 52 weeks is USD 55.37 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

LSE: AGL.L

ANGLE plc

CEO	Mr. Andrew David William Newland ACA, Meng
IPO Date	March 17, 2004
Location	United Kingdom
Headquarters	Surrey Research Park
Employees	150
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Key trends

Past 5 years